About Taiho

Research centers specialized in the areas of oncology, allergy/immunology, and urology cooperate seamlessly as they pursue research and development of innovative new drugs.

This center is responsible for quality assurance management, safety management, and regulatory affairs.

This division provides information on the company's prescription drugs to medical facilities. It also provides quality and safety infor-mation, mainly in the field of oncology, while establishing relationships of trust with medical care professionals.

This division manages information on the efficacy and safety of prescription drugs developed by Taiho for cancer treatment. It provides this information to medical care professionals in Japan and other parts of Asia and promotes the proper use of drugs.

This division manages marketing activities for over the counter (OTC) drugs available at pharmacies, and other retail outlets. The rich lineup of items helps support customers' self medication needs.

This division licenses prescription drugs researched and developed by Taiho to companies outside Japan and actively carries out post-marketing drug development.

This division uses state-of-the-art manufacturing technology and advanced quality control systems to provide the market with a stable supply of safe and high-quality pharmaceuticals.